Trading a ORKA straddle lets you take a pure volatility position on Oruka Therapeutics Inc without committing to a direction. Oruka Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ORKA straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ORKA profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Oruka Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ORKA straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ORKA straddle is the cleanest expression of that view. Our scanner prices every ORKA straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ORKA straddle into a catalyst or short a ORKA straddle to harvest decay, the options straddle setups that matter are all in one place.
